Macrobid and Faslodex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline) and Faslodex (fulvestrant). Common drug interactions include bone disorder among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Macrobid and Faslodex. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,215 Macrobid users. Check the latest studies of Macrobid.

What is Faslodex?

Faslodex has active ingredients of fulvestrant. It is often used in breast cancer metastatic. eHealthMe is studying from 19,255 Faslodex users. Check the latest studies of Faslodex.



On Aug, 06, 2026

43 people who take Macrobid and Faslodex together, and have interactions are studied.

Macrobid and Faslodex drug interactions.

What are the common drug interactions of Macrobid and Faslodex, by gender? *:

female:

  1. Bone disorder
  2. Constipation
  3. Myalgia (muscle pain)
  4. Stomatitis (inflammation of mucous membrane of mouth)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Back pain
  7. Cellulitis (infection under the skin)
  8. Emotional distress
  9. Facial pain
  10. Gingival disorder (gum disease)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Gingival disorder (gum disease)
  4. Heart rate irregular
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Hypertension (high blood pressure)
  7. Injury
  8. Neck pain
  9. Oral candidiasis (fungal infection of mouth)
  10. Osteolysis (dissolution of bone)

What are the common drug interactions of Macrobid and Faslodex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Scar
  2. Acute sinusitis
  3. Anaemia (lack of blood)
  4. Angiopathy (generic term for a disease of the blood vessels)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Arthropathy
  9. Back pain
  10. Bone disorder

10-19:

n/a

20-29:

n/a

30-39:

  1. Disease progression

40-49:

  1. Abdominal pain
  2. Arthralgia (joint pain)
  3. Benign neoplasm of thyroid gland (benign (non-cancerous) tumours of the thyroid gland)
  4. Bone disorder
  5. Colon neoplasm (cancer from uncontrolled cell growth in the colon or rectum)
  6. Decreased interest
  7. Defaecation urgency (a sudden compelling urge to defecate)
  8. Depression
  9. Dysfunctional uterine bleeding
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Anxiety
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  5. Blood cholesterol increased
  6. Cardiac failure congestive
  7. Cardiac murmur (an heart sound in valve abnormality)
  8. Cardiomyopathy (weakening of the heart muscle)
  9. Cluster headache (one-sided head pain with tearing)
  10. Coma (state of unconsciousness lasting more than six hours)

60+:

  1. Pain
  2. Bone disorder
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Cellulitis (infection under the skin)
  5. Discomfort
  6. Gingival bleeding (bleeding gums)
  7. Gingival disorder (gum disease)
  8. Heart rate irregular
  9. Osteolysis (dissolution of bone)
  10. Osteonecrosis of jaw (death of bone of jaw)

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 19 people, 44.19%
  2. Osteoporosis (bones weak and more likely to break): 17 people, 39.53%
  3. Depression: 8 people, 18.60%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 18.60%
  5. Pain: 4 people, 9.30%
  6. Breast Cancer: 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

Do you take Macrobid and Faslodex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Macrobid and Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Faslodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Faslodex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitrofurantoin; nitrofurantoin, macrocrystalline and fulvestrant (the active ingredients of Macrobid and Faslodex, respectively), and Macrobid and Faslodex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: